Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 90,000 | reported | 02 Jan 2026 | tx 3+170,000 |
| Immunome Inc. | 18,864 | reported | 10 Jun 2025 | tx 3+71,735 |
| Zenas BioPharma, Inc. | 18,500 | reported | 10 Jun 2025 | tx 2+55,500 |
| Camp4 Therapeutics Corp | 9,000 | reported | 25 Jun 2025 | tx 1+9,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | Camp4 Therapeutics Corp | 9,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Immunome Inc. | 18,864 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Zenas BioPharma, Inc. | 18,500 | 0.00 USD | deriv |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 12 Sept 2024 | GRANT_AWARD | Zenas BioPharma, Inc. | 37,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Immunome Inc. | 11,333 | 0.00 USD | deriv |
| 08 Mar 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 27 Oct 2023 | GRANT_AWARD | Immunome Inc. | 41,538 | 0.00 USD | deriv |